SCHEMBL7017627

SCHEMBL7017627

O=C(O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4ccccc4OC(F)(F)F)c3)ccc2[nH]1

nearest known ligand 0.51

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.51
TEK Q02763 9/20 0.51
MTOR P42345 2/20 0.46
P2RY1 P47900 1/20 0.44
BRAF P15056 2/20 0.43
CDK8 P49336 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5351772 0.91 KDR (0.62) KDRTEKBRAF
SCHEMBL7015248 0.89 KDR (0.54) KDRTEKMTORBRAF
SCHEMBL7017029 0.84 KDR (0.65) KDRTEKMTORBRAFCDK8
SCHEMBL7013996 0.84 KDR (0.50) KDRTEKMTORBRAF
SCHEMBL7178082 0.83 KDR (0.49) KDRTEKMTORCDK8
SCHEMBL5360482 0.82 KDR (0.66) KDRTEKBRAF
SCHEMBL7095826 0.82 KDR (0.66) KDRTEKMTORBRAF
SCHEMBL7014470 0.81 KDR (0.63) KDRTEKMTOR
SCHEMBL5342331 0.81 KDR (0.63) KDRTEKMTORCDK8
Hydrochloric Acid SCHEMBL5345130 0.81 KDR (0.62) KDRTEKMTORCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1341771-A2 BENZIMIDAZOLE DERIVATIVES USEFUL AS TIE-2 AND/OR VEGFR-2 INHIBITORS GLAXO GROUP LIMITED (GB) 2003-09-10 EP claimed
WO-2002044156-A2 BENZIMIDAZOLE DERIVATIVES USEFUL AS TIE-2 AND/OR VEGFR-2 INHIBITORS GLAXO GROUP LIMITED (GB) 2002-06-06 WO claimed
EP-1341771-A2 BENZIMIDAZOLE DERIVATIVES USEFUL AS TIE-2 AND/OR VEGFR-2 INHIBITORS GLAXO GROUP LIMITED (GB) 2003-09-10 EP disclosed
WO-2002044156-A2 BENZIMIDAZOLE DERIVATIVES USEFUL AS TIE-2 AND/OR VEGFR-2 INHIBITORS GLAXO GROUP LIMITED (GB) 2002-06-06 WO disclosed